Search

everythinglearnresearchcommunity

for

Search:↓

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Adopting the Mark Cuban Cost Plus Drug Company pricing model could save Medicare about $1.29 billion on urological drugs.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

FR-1 reduces skin scarring and promotes healing without harmful effects.

Cubosomes improve drug delivery for skin and eye diseases by enhancing adhesion, retention, and release.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

New treatments for PCOS using smart drug delivery, metabolic changes, and AI show promise but need more research.

Microneedles could revolutionize pediatric medicine by offering painless drug delivery, but more development is needed.

Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.

iEdgePathDDA effectively finds new drug-disease links, outperforming other methods.

Diet may influence acne development.

A blood pressure drug, diltiazem, may also help treat influenza.

Drug repurposing can be cost-effective but needs more testing for safety and effectiveness.

Nanocomposite patches improve drug delivery through the skin, offering controlled release and fewer side effects.

Nanoformulations improve drug delivery through the skin, reducing side effects and enhancing effectiveness.

Hydrogel-forming microneedles are promising for safe, efficient, and controlled drug delivery through the skin.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Swellable microneedles could improve drug delivery and diagnostics but need more research on materials and technology integration.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

The new adhesive nanoparticles are effective for delivering Minoxidil to the scalp without skin irritation.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.